AGP Executive Report
Last update: 2 hours agoVaccine Trial: A revised hepatitis B study involving 14,000 newborns in Guinea-Bissau has received new ethics approvals. Half the infants would get the vaccine at birth; the rest would wait until six weeks. The protocol excludes babies whose mothers test positive, but critics say delaying protection remains risky, and final national authorization is still reported as pending. Election Delay: The military authorities say conditions are not in place for the December 6 elections, with no new date announced. ECOWAS is urging broad, transparent talks on a revised timetable, as the delay deepens doubts over the junta’s promise to restore civilian rule.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.